ArticleJournal of water and health2025
Multipathway health risk assessment on disinfection byproducts of drinking water in central China: a study of 15,280 samples.
Article in Journal of water and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Health risk assessment of disinfection by-products in drinking water on children and adolescents aged 6-17 in Ningbo city, China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Disinfection is essential for protecting human health from microorganisms in drinking water. In addition to killing microorganisms, disinfection can introduce disinfection byproducts (DBPs), which impose detrimental effects on human health. In this study, a total of 15,280 water samples were monitored in 120 counties of Hunan Province, Central China, in periods ranging from 1 July 2023 to 31 December 2024. We evaluated the health risks of DBPs in drinking water through various exposure routes and conducted a comprehensive analysis of different factors that impact the health risks associated with these DBPs. The overall carcinogenic and noncarcinogenic risks resulting from exposure to DBPs through multiple pathways were 1.15 × 10
Indexed as
Identifiers
40586342What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.